Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Sinopharm paid $252 million to purchase a 57% stake in...
OrbiMed Advisors will raise $300 million for a new...
Amgen signed a MOU with ShanghaiTech University under...
iKang Healthcare Group, the largest private provider of...
WuXi PharmaTech raised $80 million for its SynTheAll...
CBT 200 Falls 6 Points. More details...
CBT 200 Rises 2.5%. More details...
Six Of Thirteen Withdrawn. More details...
Big Gains in 2006 According to an article in the Wall...
Deals, Products and New Trials Announced -- In the last...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
